Novavax Inc. Stock Advances 10.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. surged 10.0% to $10.65 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.4% to 25,736.51 and the Dow Jones Industrial Average rising 3.0% to 53,356.12.

This was the stock's second consecutive day of gains.

Novavax Inc. closed 20.4% below its 52-week high of $13.39, which the company reached on October 5th.

The stock outperformed some of its peers, as Johnson & Johnson rose 3.8% to $276.32, Pfizer Inc. rose 2.6% to $30.79, and Merck & Co. Inc. rose 3.93% to $150.36.

Trading volume totaled 5.9 million, compared to the 50-day average of 6.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 04, 2026 16:35 ET (21:35 GMT)